{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:33:37Z","timestamp":1790037217057,"version":"4.0.1"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Sickle cell disease (SCD) is major inherited disease linked to a pro-inflammatory state, with a widespread involvement seen in all organ systems with lungs being no different. This research aims to analyze pulmonary function tests and fractional exhaled nitric oxide (FeNO) levels of children diagnosed with SCD and comparing them with healthy controls.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>The study involved 100 children with SCD in stable state of health, without pain, crises, or acute illnesses for at least 1-month, and aged between 6\u201320 years and 100 age- and height-matched controls. Those with spinal deformities, acute or chronic cardiorespiratory symptoms, and cigarette smoking (in parents) were excluded. Measurements of forced vital capacity(FVC) and forced expiratory volume in one second(FEV1) were conducted using an automated single-breath vitalograph. FeNO was recorded using a hand-held device(NIOX MINO). Data werecollected and analyzed<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Children with SCD had significantly lower pulmonary function values compared to controls: FEV1 median difference: 33.5% (95% CI: 27.2\u201338.0; p\u2009&lt;\u20090.0001), FVC: 25.4% (95% CI: 30.0\u201332.25; p\u2009&lt;\u20090.0001), FEV1\/FVC: 0.088 (95% CI: 0.075\u20130.083; p\u2009&lt;\u20090.0001), Peak Expiratory Flow Rate (PEFR): 24.8% (95% CI: 16.38\u201333.8; p\u2009&lt;\u20090.0001), FeNO: 8.17 ppb (95% CI: 5.77\u201312.65; p\u2009&lt;\u20090.0001). Pulmonary function test (PFT) abnormalities were associated with younger age (p\u2009=\u20090.0022). Age (p\u2009=\u20090.0011) was significantly associated with PFT severity, while blood transfusion frequency, and fractional exhaled nitric oxide (FeNO) levels were not. Increased weight (p\u2009=\u20090.001) and longer duration of hydroxyurea (p\u2009=\u20090.011) were associated with improved PFT severity (based on FEV1 z-scores).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Children with SCD often exhibit restrictive, obstructive, or mixed pulmonary function patterns. FeNO levels donot correlate with PFT severity.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0329064","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:26:47Z","timestamp":1753723607000},"page":"e0329064","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["The pattern of lung function tests in children with sickle cell disease: A case-control study"],"prefix":"10.1371","volume":"20","author":[{"given":"Abinaya","family":"Kannan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Sarnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0504-1077","authenticated-orcid":true,"given":"Atul","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"1","key":"pone.0329064.ref001","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12288-014-0407-z","article-title":"The screening and morbidity pattern of sickle cell anemia in chhattisgarh","volume":"31","author":"S Panigrahi","year":"2015","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"23","key":"pone.0329064.ref002","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"OS Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"25","key":"pone.0329064.ref003","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group","volume":"342","author":"EP Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0329064.ref004","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1164\/rccm.200610-1498OC","article-title":"Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension","volume":"175","author":"A Anthi","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"pone.0329064.ref005","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ccm.2024.02.022","article-title":"Updates in Pediatric Sickle Cell Lung Disease","volume":"45","author":"M Gillespie","year":"2024","journal-title":"Clinics in Chest Medicine"},{"key":"pone.0329064.ref006","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1100\/tsw.2011.105","article-title":"Asthma in sickle cell disease","volume":"11","author":"M Newaskar","year":"2011","journal-title":"ScientificWorldJournal"},{"issue":"7","key":"pone.0329064.ref007","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1164\/rccm.200710-1542OC","article-title":"Alterations of the arginine metabolome in asthma","volume":"178","author":"A Lara","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0329064.ref008","first-page":"33","article-title":"Lung function in sickle cell disease","volume":"15","author":"AC Koumbourlis","year":"2014","journal-title":"Paediatr Respir Rev"},{"issue":"5","key":"pone.0329064.ref009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.06.043","article-title":"Exhaled nitric oxide: Not associated with asthma, symptoms, or spirometry in children with sickle cell anemia","volume":"138","author":"RT Cohen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"pone.0329064.ref010","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1164\/ajrccm.164.12.2012090","article-title":"Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome","volume":"164","author":"KJ Sullivan","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0329064.ref011","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jpeds.2011.06.048","article-title":"Lower airway nitric oxide is increased in children with sickle cell disease","volume":"160","author":"DK Radhakrishnan","year":"2012","journal-title":"J Pediatr"},{"issue":"3","key":"pone.0329064.ref012","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1476-5381.2009.00374.x","article-title":"Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives","volume":"158","author":"H Maarsingh","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"8","key":"pone.0329064.ref013","article-title":"Standardization of Spirometry 2019 Update","volume":"200","author":"BL Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"pone.0329064.ref014","first-page":"359","article-title":"A stepwise approach to the interpretation of pulmonary function tests","volume":"89","author":"JD Johnson","year":"2014","journal-title":"Am Fam Physician"},{"issue":"13","key":"pone.0329064.ref015","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.3390\/jcm13133655","article-title":"Pulmonary Function Tests: Easy Interpretation in Three Steps","volume":"13","author":"J Ora","year":"2024","journal-title":"J Clin Med"},{"issue":"5","key":"pone.0329064.ref016","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"RA Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"pone.0329064.ref017","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/ppul.24871","article-title":"Pulmonary functions in children and adolescents with sickle cell disease","volume":"55","author":"M Al Biltagi","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"pone.0329064.ref018","article-title":"Variation in pulmonary function tests among children with sickle cell anemia: a systematic review and meta-analysis","volume":"39","author":"A Taksande","year":"2021","journal-title":"Pan African Medical Journal"},{"issue":"3","key":"pone.0329064.ref019","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/MPH.0000000000000011","article-title":"Abnormal pulmonary function and associated risk factors in children and adolescents with sickle cell anemia","volume":"36","author":"M Arteta","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"pone.0329064.ref020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000485801","article-title":"Correlates of Pulmonary Function in Children with Sickle Cell Disease and Elevated Fetal Hemoglobin","volume":"27","author":"AD Adekile","year":"2018","journal-title":"Med Princ Pract"},{"issue":"9","key":"pone.0329064.ref021","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/17512433.2024.2390915","article-title":"Hydroxyurea in the sickle cell disease modern era","volume":"17","author":"C Riley","year":"2024","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"pone.0329064.ref022","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ajh.10284","article-title":"Decreased exhaled nitric oxide in sickle cell disease: relationship with chronic lung involvement","volume":"72","author":"RE Girgis","year":"2003","journal-title":"Am J Hematol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0329064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:26:52Z","timestamp":1753723612000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0329064"}},"subtitle":[],"editor":[{"given":"Santosh L.","family":"Saraf,","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":22,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0329064","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}